GHRL and metabolic syndrome: Multiple studies have associated ghrelin with the inhibition of atherosclerotic plaque formation and promotion of plaque stability [33,34,35,36], with observations of lower circulating ghrelin levels in obese patients with metabolic syndrome [37].